Mercer Global Advisors
EDSA icon

Mercer Global Advisors’s Edesa Biotech EDSA Stock Holding History

Mercer Global Advisors’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301 Buy
+37
New +$334 ﹤0.01% 5886

Other funds holding EDSA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mercer Global Advisors's EDSA Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Edesa Biotech (EDSA) in Q2 2026: 37 shares worth $301. The stake represents ﹤0.01% of the portfolio and ranks #5886 among its holdings.

20 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • Mercer Global Advisors held 37 shares of Edesa Biotech worth $301 as of Q2 2026.
  • Edesa Biotech was a new Mercer Global Advisors position in Q2 2026.
  • Edesa Biotech made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5886 holding.
  • 20 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.